164 results on '"Shaffer, Arthur L."'
Search Results
2. Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14
3. Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma
4. Control of Inflammation, Cytokine Expression, and Germinal Center Formation by BCL-6
5. Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2
6. Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1
7. ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans
8. Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors
9. Dendritic cell fate is determined by BCL11A
10. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
11. In vivo CRISPR screens reveal a HIF-1α-mTOR-network regulates T follicular helper versus Th1 cells
12. Control of Autophagic Cell Death by Caspase-10 in Multiple Myeloma
13. Prolonged early G1 arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle–coupled loss of IRF4
14. Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
15. A Prospective Study of Clonal Evolution in Follicular Lymphoma: Circulating Tumor DNA Correlates with Overall Tumor Burden and Fluctuates over Time without Therapy
16. A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression
17. Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation
18. Overcoming Acquired Epigenetic Resistance to BTK Inhibitors
19. Cooperative Epigenetic Modulation by Cancer Amplicon Genes
20. Integration and Iteration: Using Advanced, High-Content Imaging and Single-Cell Gene Expression Analysis to Uncover Unique Aspects of Follicular Lymphoma Biology
21. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
22. Prostaglandin E2 Suppresses Antifungal Immunity by Inhibiting Interferon Regulatory Factor 4 Function and Interleukin-17 Expression in T Cells
23. Oncogenically active MYD88 mutations in human lymphoma
24. KLHL14 Is a Tumor Suppressor in Diffuse Large B-Cell Lymphoma
25. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
26. IRF4 addiction in multiple myeloma
27. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro
28. TLR Signaling Is Activated in Lymph Node–Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib
29. Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma
30. CDDO-Imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasms
31. Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells
32. Molecular and cytological features of the mouse B-cell lymphoma line iMycEμ-1
33. Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14.
34. A multiprotein supercomplex controlling oncogenic signalling in lymphoma
35. Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T-Cell Leukemia/Lymphoma
36. Retraction for Lee et al., “The BCL11A Transcription Factor Directly Activates RAG Gene Expression and V(D)J Recombination”
37. A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm
38. Cell intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses1
39. Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma
40. Selective interleukin-1 receptor–associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy
41. Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma.
42. The BCL11A Transcription Factor Directly Activates RAG Gene Expression and V(D)J Recombination
43. Abstract LB-248: IRF4 as a critical regulator and potential therapeutic target in ABC type diffuse large B-cell lymphoma
44. Oncogenically active MYD88 mutations in human lymphoma
45. Bortezomib Resistance in Mantle Cell Lymphoma Is Associated with Expression of a Plasmacytoid Differentiation Program.
46. IRF4: Immunity. Malignancy! Therapy?
47. Repression of BCL-6 is required for the formation of human memory B cells in vitro
48. CDDO-Imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasms
49. Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells
50. Transformation of Late Passage Insulin-Like Growth Factor-I Receptor Null Mouse Embryo Fibroblasts by SV40 T Antigen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.